A counterintuitive philosophy is gaining traction among healthcare strategists: building specialty drug networks that begin with a narrow, focused footprint rather than broad reach. That argument was put forward by three industry
Genus (GNS), the animal genetics company listed on the London Stock Exchange, has seen its share price come under pressure, prompting analysts to flag a potential entry point for investors. The stock
More
The full phase 3 dataset from Merck (MRK) and Gilead’s (GILD) failed Trodelvy trial in first-line non-small cell lung cancer has now been made public, raising significant questions for the industry. The
More
Maryland has amended its Maryland Franchise Registration and Disclosure Law, with all changes coming into effect on October 1, 2026, reshaping obligations for franchisors operating in the state. Franchisors registered in Maryland
More
Weil, Gotshal & Manges has suffered a significant departure as Michael Aiello, chair of its roughly 600-lawyer corporate department, heads to rival firm Cravath, Swaine & Moore. Aiello also holds a seat
More
Deere & Company (DE) appears to be trading at a significant discount to its estimated fair value, with analysts suggesting shares may be undervalued by as much as 11%. The agricultural and
More
iShares FTSE 250, the exchange-traded fund tracking mid-cap UK listed companies, has announced a new dividend declaration for its sterling share class. The fund, managed by BlackRock (BLK), is one of the
More
AstraZeneca’s (AZN) camizestrant, branded Etcamah, has failed to demonstrate a statistically significant improvement in a major Phase III breast cancer trial, dealing a blow to the drug’s broader commercial ambitions. The SERENA-4
More
The Supreme Court’s decision to strike down International Emergency Economic Powers Act tariffs triggered a major refund process, but new complications are emerging for importers across the United States. US Customs and
More
A federal appellate opinion from the First Circuit has drawn widespread attention for its strikingly casual writing style, prompting debate across the legal community. The opinion, written by Judge O. Rogeriee Thompson,
More
Associated British Foods (LSE: ABF) saw its shares collapse by more than 10% in a single trading session after the company released its fourth-quarter results last September. The results painted a mixed
More